DiscoverSurgical Hot TopicsBeyond the Abstract: Does tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?
Beyond the Abstract: Does tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?

Beyond the Abstract: Does tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?

Update: 2020-05-29
Share

Description

The death rate from cancer has steadily declined over the past 25 years; however, worldwide there were 9.6 million deaths in 2018, with lung cancer still number one among all cancer types. In the latest episode of “Beyond the Abstract,” a program that explores the “whys” behind an article in The Annals of Thoracic Surgery, Dr. Kemp H. Kernstine joins host Dr. Tom Varghese to discuss whether tumor FDG-PET avidity represents enhanced glycolytic metabolism in non-small cell lung cancer. Read the related Annals article online: https://bit.ly/3c9sXm5.

Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Beyond the Abstract: Does tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?

Beyond the Abstract: Does tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?

The Society of Thoracic Surgeons